Johnson & Johnson (JNJ) PT Raised to $195 at Wolfe Research, 'increased confidence in JNJ's upcoming talc litigation outcome'
Tweet Send to a Friend
Wolfe Research analyst Alexandria Hammond raised the price target on Johnson & Johnson (NYSE: JNJ) to $195.00 (from $175.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
